Your session is about to expire
← Back to Search
Remote Ischemic Preconditioning for Contrast-Induced Acute Kidney Injury (RIP-CI-AKI Trial)
RIP-CI-AKI Trial Summary
This trial will test the feasibility, safety, and effectiveness of remote ischemic preconditioning (RIPC) as a means of reducing the incidence of contrast-induced nephropathy (CI-AKI) in patients undergoing coronary angiography (CA) or other diagnostic contrast studies.
RIP-CI-AKI Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowRIP-CI-AKI Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RIP-CI-AKI Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your systolic blood pressure is less than 80 mmHg.It will be hard for us to get information from you 6 weeks after the study starts.I am having a procedure that involves dye in my veins, except for emergency heart artery opening.I have had a procedure to block blood flow to my kidney.I need medication through an IV for a severe heart condition.You had a contrast dye injection in the past 30 days.You have Raynaud's disease.I need an urgent heart artery exam due to a severe heart attack.I am currently on dialysis.I cannot have RIPC due to conditions in both arms.I am under 18 years old.You have an intra-aortic balloon pump.My kidney function is low but I don't have end-stage renal disease.
- Group 1: Remote Ischemic Preconditioning Protocol
- Group 2: Sham Preconditioning Protocol
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the maximum number of participants currently approved for this trial?
"Confirmed. Per the clinicaltrials.gov website, this investigation is actively recruiting participants as of today. It was initially posted on November 30th 2021 with its most recent edit occurring April 14th 2022; 300 volunteers are needed at a single medical facility to complete the trial's goals."
Does this investigation still accept new participants?
"As indicated on clinicaltrials.gov, this study is actively enlisting patients; the original posting was made on November 30th 2021 with a subsequent update released April 14th 2022."
Share this study with friends
Copy Link
Messenger